Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Protection of pregnant women at work in Switzerland: practices, obstacles and resources. A mixed-methods study protocol.

Krief P, Zellweger A, Politis Mercier MP, Danuser B, Wild P, Zenoni M, Probst I.

BMJ Open. 2018 Jun 14;8(6):e023532. doi: 10.1136/bmjopen-2018-023532.

2.

Exposure to field vs. storage wheat dust: different consequences on respiratory symptoms and immune response among grain workers.

Barrera C, Wild P, Dorribo V, Savova-Bianchi D, Laboissière A, Pralong JA, Danuser B, Krief P, Millon L, Reboux G, Niculita-Hirzel H.

Int Arch Occup Environ Health. 2018 Aug;91(6):745-757. doi: 10.1007/s00420-018-1322-7. Epub 2018 May 26.

PMID:
29804141
3.

Nasal fibroscopy as a routine screening procedure of sinonasal adenocarcinoma of woodworkers: French longitudinal case study.

Martin J, Vayr F, Paris C, Vergez S, Krief P, Luc A, Corvisier J; CERBois members, de Gabory L, Herin F.

Head Neck. 2018 May 13. doi: 10.1002/hed.25315. [Epub ahead of print]

PMID:
29756404
4.

GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.

Guerenne L, Beurlet S, Said M, Gorombei P, Le Pogam C, Guidez F, de la Grange P, Omidvar N, Vanneaux V, Mills K, Mufti GJ, Sarda-Mantel L, Noguera ME, Pla M, Fenaux P, Padua RA, Chomienne C, Krief P.

J Hematol Oncol. 2016 Jan 27;9:5. doi: 10.1186/s13045-016-0235-8.

5.

Respiratory health effects of fifteen years of improved collective protection in a wheat-processing worker population.

Dorribo V, Wild P, Pralong JA, Danuser B, Reboux G, Krief P, Niculita-Hirzel H.

Ann Agric Environ Med. 2015;22(4):647-54. doi: 10.5604/12321966.1185768.

6.

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.

Patel S, Guerenne L, Gorombei P, Omidvar N, Schlageter MH, Alex AA, Ganesan S, West R, Adès L, Mathews V, Krief P, Pla M, Fenaux P, Chomienne C, Padua RA.

Blood Cancer J. 2015 Dec 11;5:e374. doi: 10.1038/bcj.2015.102. No abstract available.

7.

DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.

Le Pogam C, Patel S, Gorombei P, Guerenne L, Krief P, Omidvar N, Tekin N, Bernasconi E, Sicre F, Schlageter MH, Chopin M, Noguera ME, West R, Abu A, Mathews V, Pla M, Fenaux P, Chomienne C, Padua RA.

Oncotarget. 2015 Oct 20;6(32):32494-508. doi: 10.18632/oncotarget.5572.

8.

[Post-occupational medical follow-up: stakes, terms, obstacles].

Krief P, Andujar P, Pairon JC.

Rev Prat. 2014 Mar;64(3):369-80. Review. French.

PMID:
24851374
9.

Karrikins from plant smoke modulate bacterial quorum sensing.

Mandabi A, Ganin H, Krief P, Rayo J, Meijler MM.

Chem Commun (Camb). 2014 May 25;50(40):5322-5. doi: 10.1039/c3cc47501h. Epub 2013 Dec 10.

PMID:
24327106
10.

Tailor-made LasR agonists modulate quorum sensing in Pseudomonas aeruginosa.

Rabin N, Delago A, Inbal B, Krief P, Meijler MM.

Org Biomol Chem. 2013 Nov 7;11(41):7155-63. doi: 10.1039/c3ob41377b.

PMID:
24057196
11.

BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.

Beurlet S, Omidvar N, Gorombei P, Krief P, Le Pogam C, Setterblad N, de la Grange P, Leboeuf C, Janin A, Noguera ME, Hervatin F, Sarda-Mantel L, Konopleva M, Andreeff M, Tu AW, Fan AC, Felsher DW, Whetton A, Pla M, West R, Fenaux P, Chomienne C, Padua RA.

Blood. 2013 Oct 17;122(16):2864-76. doi: 10.1182/blood-2012-07-445635. Epub 2013 Aug 13.

12.

The bacterial quorum-sensing signal molecule N-3-oxo-dodecanoyl-L-homoserine lactone reciprocally modulates pro- and anti-inflammatory cytokines in activated macrophages.

Glucksam-Galnoy Y, Sananes R, Silberstein N, Krief P, Kravchenko VV, Meijler MM, Zor T.

J Immunol. 2013 Jul 1;191(1):337-44. doi: 10.4049/jimmunol.1300368. Epub 2013 May 29.

13.

Species selective diazirine positioning in tag-free photoactive quorum sensing probes.

Dubinsky L, Delago A, Amara N, Krief P, Rayo J, Zor T, Kravchenko VV, Meijler MM.

Chem Commun (Camb). 2013 Jul 4;49(52):5826-8. doi: 10.1039/c3cc43092h. Epub 2013 May 24.

14.

Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes.

Le Pogam C, Krief P, Beurlet S, Soulié A, Balitrand N, Cassinat B, Cavé H, Kosmider O, Setterblad N, Leboeuf C, Sarda-Mantel L, Hervatin F, Merlet P, Noguera ME, Janin A, Pla M, Fontenay M, Adès L, Fenaux P, Chomienne C, Padua RA, Omidvar N.

Leuk Res. 2013 Mar;37(3):312-9. doi: 10.1016/j.leukres.2012.10.018. Epub 2012 Nov 12.

PMID:
23153525
15.

Facial leucoderma following eczema: a new case induced by spectacle frames.

Crépy MN, Bensefa-Colas L, Krief P, Langlois E, Guillemot M, Choudat D.

Contact Dermatitis. 2011 Oct;65(4):243-5. doi: 10.1111/j.1600-0536.2011.01954.x. No abstract available.

PMID:
21906075
16.

Assessment of nasal fibroscopy to explore olfactory cleft.

Porez F, de Pommerol MJ, Krief P, Conso F, Stoll D, de Gabory L.

Otolaryngol Head Neck Surg. 2011 Oct;145(4):677-82. doi: 10.1177/0194599811410273. Epub 2011 May 27.

PMID:
21622802
17.

Live cell labeling of native intracellular bacterial receptors using aniline-catalyzed oxime ligation.

Rayo J, Amara N, Krief P, Meijler MM.

J Am Chem Soc. 2011 May 18;133(19):7469-75. doi: 10.1021/ja200455d. Epub 2011 Apr 22.

PMID:
21513325
18.

Identification of JAK2 mutations in canine primary polycythemia.

Beurlet S, Krief P, Sansonetti A, Briend-Marchal A, Kiladjian JJ, Padua RA, Chomienne C, Cassinat B.

Exp Hematol. 2011 May;39(5):542-5. doi: 10.1016/j.exphem.2011.02.003. Epub 2011 Feb 12.

PMID:
21320566
19.

Fifteen-year-old girl with systemic lupus erythematosus and unilateral cerebellitis.

Krief P, Silver A, Eberhard A, Maytal J.

Lupus. 2010 Jul;19(8):981-4. doi: 10.1177/0961203309356457. Epub 2010 Jan 12.

PMID:
20068015
20.

Synthesis and validation of a probe to identify quorum sensing receptors.

Dubinsky L, Jarosz LM, Amara N, Krief P, Kravchenko VV, Krom BP, Meijler MM.

Chem Commun (Camb). 2009 Dec 21;(47):7378-80. doi: 10.1039/b917507e. Epub 2009 Oct 28.

PMID:
20024234
21.

DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model.

Furugaki K, Pokorna K, Le Pogam C, Aoki M, Reboul M, Bajzik V, Krief P, Janin A, Noguera ME, West R, Charron D, Chomienne C, Pla M, Moins-Teisserenc H, Padua RA.

Blood. 2010 Jan 21;115(3):653-6. doi: 10.1182/blood-2007-08-109009. Epub 2009 Nov 19.

22.

Covalent inhibition of bacterial quorum sensing.

Amara N, Mashiach R, Amar D, Krief P, Spieser SA, Bottomley MJ, Aharoni A, Meijler MM.

J Am Chem Soc. 2009 Aug 5;131(30):10610-9. doi: 10.1021/ja903292v.

PMID:
19585989
23.

Electrochemical analysis of quorum sensing inhibition.

Bukelman O, Amara N, Mashiach R, Krief P, Meijler MM, Alfonta L.

Chem Commun (Camb). 2009 May 28;(20):2836-8. doi: 10.1039/b901125k. Epub 2009 Mar 9.

PMID:
19436882
24.

Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.

Krief P, Li Kan, Maytal J.

J Child Neurol. 2008 May;23(5):582-4. doi: 10.1177/0883073807309781.

PMID:
18448575
25.

Is ethmoidal adenocarcinoma screening in employees exposed to wood dust justified?

De Gabory L, Conso F, Krief P, Stoll D.

Rev Laryngol Otol Rhinol (Bord). 2008;129(4-5):219-26. Review.

PMID:
19408499
26.

An 8-bp deletion in mNOTCH4 intron 10 leads to its retention in mRNA and to synthesis of a truncated protein.

Auffray C, Gayon R, Benraiss A, Martin N, Laurendeau I, Garaud J, Lucas B, Boitard C, Krief P.

Exp Cell Res. 2006 Feb 1;312(3):233-44. Epub 2005 Nov 21.

PMID:
16300754
27.

Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal mice.

Faideau B, Briand JP, Lotton C, Tardivel I, Halbout P, Jami J, Elliott JF, Krief P, Muller S, Boitard C, Carel JC.

J Immunol. 2004 Jan 1;172(1):25-33.

28.

Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.

Thébault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, Morin J, Laloux V, Lehuen A, Carel JC, Jami J, Muller S, Boitard C.

J Clin Invest. 2003 Mar;111(6):851-7.

29.

Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes.

Dubois-Lafforgue D, Mogenet L, Thébault K, Jami J, Krief P, Boitard C.

Diabetes. 2002 Dec;51 Suppl 3:S489-93.

30.

Oxidation of TTF derivatives using (diacetoxyiodo)benzene: a general chemical route toward cation radicals, dications, and nonstoichiometric salts.

Giffard M, Mabon G, Leclair E, Mercier N, Allain M, Gorgues A, Molinié P, Neilands O, Krief P, Khodorkovsky V.

J Am Chem Soc. 2001 Apr 25;123(16):3852-3. No abstract available.

PMID:
11457131
31.

Mitogenic effect of fibrinogen on hematopoietic cells: involvement of two distinct specific receptors, MFR and ICAM-1.

Héron A, Lévesque JP, Hatzfeld A, Kisselev S, Monier MN, Krief P, Hatzfeld J.

Biochem Biophys Res Commun. 1998 May 8;246(1):231-7.

PMID:
9600098
32.

Implication of a new molecule IK in CD34+ hematopoietic progenitor cell proliferation and differentiation.

Cao LX, Le Bousse-Kerdiles MC, Clay D, Oshevski S, Jasmin C, Krief P.

Blood. 1997 May 15;89(10):3615-23.

33.

Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line.

Vedrenne J, Assier E, Pereno R, Bouzinba-Segard H, Azzarone B, Jasmin C, Charron D, Krief P.

Oncogene. 1997 Mar 27;14(12):1453-61.

34.

Are interleukin-2 and interleukin-15 tumor promoting factors for human non-hematopoietic cells?

Azzarone B, Pottin-Clemenceau C, Krief P, Rubinstein E, Jasmin C, Scudeletti M, Indiveri F.

Eur Cytokine Netw. 1996 Jan-Mar;7(1):27-36. Review.

PMID:
8704093
35.

Purification and characterization of a factor which inhibits retrovirus replication.

Krief P, Lawrence D, Alileche A, Plaisance S, Jasmin C, Semmel M.

Res Virol. 1995 Mar-Apr;146(2):113-23.

PMID:
7638435
36.

A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization.

Krief P, Augery-Bourget Y, Plaisance S, Merck MF, Assier E, Tanchou V, Billard M, Boucheix C, Jasmin C, Azzarone B.

Oncogene. 1994 Dec;9(12):3449-56.

PMID:
7970704
37.

Expression of the interleukin-2 receptor on human fibroblasts and its biological significance.

Plaisance S, Rubinstein E, Alileche A, Sahraoui Y, Krief P, Augery-Bourget Y, Jasmin C, Suarez H, Azzarone B.

Int Immunol. 1992 Jul;4(7):739-46.

PMID:
1379826
38.

Inhibition of human immunodeficiency virus (HIV) type 1 multiplication by an avian cellular factor.

Semmel M, Alileche A, Coulaud D, Aguilar J, Krief P, Jasmin C.

Arch Virol. 1992;123(3-4):309-21.

PMID:
1314050
39.
40.

The role of growth-factor receptors (excluding IL-2 receptors) in the proliferation and differentiation of normal and leukemic hematopoietic cells.

Jasmin C, Allouche M, Le Bousse-Kerdiles C, Smadja-Joffe F, Krief P, Georgoulias V, Boucheix C.

Leuk Res. 1990;14(8):695-8. Review.

PMID:
2167408
41.

Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin beta 3 and increased expression of c-myc.

Krief P, Saint-Ruf C, Bracke M, Boucheix C, Billard C, Billard M, Cassingena R, Jasmin C, Mareel M, Azzarone B.

Int J Cancer. 1989 Apr 15;43(4):658-64.

PMID:
2495251
42.

High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T-cell type origin.

Venuat AM, Soria C, Soria J, Krief P, Mirshahi M, He L, Thomaidis A, Houllier A, Billard M, Boucheix C.

Cancer. 1988 Nov 1;62(9):1952-7.

PMID:
3167807
43.

Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells.

Lu H, Mirshahi M, Krief P, Soria C, Soria J, Mishal Z, Bertrand O, Perrot JY, Li H, Picot C, et al.

Biochem Biophys Res Commun. 1988 Aug 30;155(1):418-22.

PMID:
2843185
44.

Human fibroblasts from cancer patients: lifespan and transformed phenotype in vitro and role of mesenchyme in vivo.

Azzarone B, Chaponnier C, Krief P, Mareel M, Suarez H, Macieira-Coelho A.

Mutat Res. 1988 Jun;199(2):313-25.

PMID:
3374507
45.

A B cell-restricted activation antigen (B8.7) functionally related to the low molecular weight B cell growth factor receptor.

Leprince C, Richard Y, Krief P, Treton D, Boucheix C, Galanaud P.

J Immunol. 1988 Jan 1;140(1):100-7.

PMID:
3257225
46.

Modulation of expression of class II histocompatibility antigens by secretion of a cellular inhibitor in K562 leukemic cells.

Krief P, Boucheix C, Billard C, Mishal Z, Van Agthoven A, Fiers W, Azzarone B.

Eur J Immunol. 1987 Jul;17(7):1021-5.

PMID:
3111856
47.

Screening monoclonal antibodies against cell-surface antigens. High frequency of natural antibodies.

Perrot JY, Krief P, Julien C, Benoit P, Mirshahi M, Billard M, Rosenfeld C, Boucheix C.

Scand J Immunol. 1986 Jun;23(6):623-9.

PMID:
3520801
48.

Method for rapid detection of membrane antigens by immunofluorescence and its application to screening monoclonal antibodies.

Boucheix C, Krief P, Perrot JY, Mirshahi M, Rosenfeld C.

Methods Enzymol. 1986;121:580-7. No abstract available.

PMID:
3523133
49.

Modulation of fibroblast-induced clot retraction by calcium channel blocking drugs and the monoclonal antibody ALB6.

Azzarone B, Krief P, Soria J, Boucheix C.

J Cell Physiol. 1985 Dec;125(3):420-6.

PMID:
3864783
50.

Evaluation of residual disease in human leukemias.

Boucheix C, Krief P, Perrot JY.

Rev Fr Transfus Immunohematol. 1985 Nov;28(5):383-90. No abstract available.

PMID:
3912917

Supplemental Content

Support Center